The Werner syndrome protein in CPT-induced DNA damage
The Werner syndrome protein in CPT-induced DNA damage
批准号:
7447381
负责人:
LUCIO COMAI
金额:
$29.69万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-06-01 至 2011-05-31
关键词:
Activation AnalysisAgeAge of OnsetAtherosclerosisBindingBiochemicalBiological AssayCamptothecinCell Cycle CheckpointCell physiologyCellsChromatinChromosomal InstabilityComplexDNADNA AdductsDNA DamageDNA Double Strand BreakDNA RepairDNA Repair PathwayDNA lesionDNA-PKcsDefectDetectionDiseaseExonucleaseFailureG22P1 geneGeneticGenomeGenome StabilityGoalsGrowthHumanHypersensitivityIndividualMalignant NeoplasmsMediatingMolecularMonitorMutagensNormal CellPathway interactionsPatientsPhasePlayPredispositionPrincipal InvestigatorProcessProteinsRNA biosynthesisRecruitment ActivityReplication OriginResearchRibosomal DNARibosomal RNARoleSiteSuicideTestingTopoisomeraseTopoisomerase-I InhibitorToxic effectType I DNA TopoisomerasesWRN geneWerner Syndromeage relatedbasehelicasehuman TOP1 proteinhuman WRN proteininsightloss of functionmutantprogramsrepairedresearch studyresponsesenescence
中文摘要
描述(申请人提供):沃纳综合征(WS)是一种常染色体隐性遗传疾病,可导致早发性衰老和衰老相关疾病,包括癌症和动脉粥样硬化。WS由WRN基因功能丧失引起。WRN基因编码RecQ解旋酶蛋白,其具有独特的外切核酸酶活性(WRN),其细胞功能知之甚少。来自WS患者的细胞表现出过早衰老和对DNA损伤剂如喜树碱(CPT)的敏感性。 重要的是,我们已经证明WRN与Ku 70/80结合,Ku 70/80是一种异二聚体复合物,已知在DNA损伤修复中起关键作用。这一观察结果有力地支持了WRN在DNA损伤反应途径中发挥作用的观点。因此,我们假设WRN是S期检查点激活所必需的,或者直接参与细胞暴露于CPT后DNA损伤的修复。具体而言,在目标I中,我们将测试WRN的丢失是否导致CPT处理的细胞中的S期检查点对照缺陷。目的2中提出的实验将研究响应CPT诱导的DNA损伤的WRN及其相关因子向染色质的募集的动态。在目标3中,我们将检验WRN的缺失导致rDNA位点的遗传不稳定性,从而导致DNA损伤后核糖体RNA生物合成异常的假设。在目标4中,将通过研究对CPT诱导的表达外切核酸酶或解旋酶活性缺陷或缺乏保守结构域的突变WRN蛋白的细胞的DNA损伤的反应来获得对这些过程的生物化学见解。总之,这些实验应该为人类衰老过程提供重要的机制见解。
英文摘要
DESCRIPTION (provided by applicant): Werner syndrome (WS) is an autosomal recessive disorder leading to premature onset aging and aging-related diseases including cancer and atherosclerosis. WS results from the loss of function of the WRN gene. The WRN gene encodes a RecQ helicase protein with a unique exonuclease activity (WRN) whose cellular function is poorly understood. Cells from WS patients demonstrate premature senescence and sensitivity to DNA damaging agents such as camptothecin (CPT). Importantly, we have shown that WRN binds to Ku70/80, a heterodimeric complex known to play a critical role in the repair of DNA damage. This observation strongly supports the idea that WRN functions in a DNA damage response pathway. We therefore hypothesize that WRN is required for S-phase checkpoint activation or is directly involved in the repair of DNA lesions following exposure of cells to CPT. Specifically, in Aim I we will test whether loss of WRN leads to defective S-phase checkpoint controls in CPT-treated cells. Experiments proposed in Aim 2 will study the dynamics of the recruitment of WRN and its associated factors to chromatin in response to CPT-induced DNA damage. In Aim 3, we will test the hypothesis that loss of WRN results in genetic instability at the rDNA locus leading to aberrant ribosomal RNAs biosynthesis upon DNA damage. In Aim 4, biochemical insights into these processes will be obtained by studying the response to CPT-induced DNA damage of cells expressing mutant WRN proteins deficient in exonuclease or helicase activity, or lacking conserved structural domains. Taken together, these experiments should provide important mechanistic insights into the process of human aging.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Processing of human telomeres by the Werner syndrome protein.
维尔纳综合征蛋白对人类端粒的加工。
DOI:
10.4161/cc.9.16.12952
发表时间:
2010
期刊:
Cell cycle (Georgetown, Tex.)
影响因子:
--
作者:
[Reddy,Sita, Li,Baomin, Comai,Lucio]
通讯作者:
Comai,Lucio
A conserved and species-specific functional interaction between the Werner syndrome-like exonuclease atWEX and the Ku heterodimer in Arabidopsis.
拟南芥中沃纳综合征样核酸外切酶 atWEX 和 Ku 异二聚体之间保守且物种特异性的功能相互作用。
DOI:
10.1093/nar/gki984
发表时间:
2005
期刊:
Nucleic acids research
影响因子:
14.9
作者:
[Li,Baomin, Conway,Nathan, Navarro,Sonia, Comai,Luca, Comai,Lucio]
通讯作者:
Comai,Lucio
Small molecule therapeutics for myotonic dystrophy type 1
-
批准号:10583984
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2023
-
负责人:LUCIO COMAI
-
依托单位:
Development and validation of a cell-based assay system to identify novel therapeutics for C9ALS/FTD
-
批准号:9978295
-
项目类别:
-
资助金额:$45.38万
-
财政年份:2020
-
负责人:LUCIO COMAI
-
依托单位:
Identification of Therapeutic Small Molecules for Myotonic Dystrophy Type 1
-
批准号:8695714
-
项目类别:
-
资助金额:$1.57万
-
财政年份:2011
-
负责人:LUCIO COMAI
-
依托单位:
Identification of Therapeutic Small Molecules for Myotonic Dystrophy Type 1
-
批准号:8258211
-
项目类别:
-
资助金额:$24.48万
-
财政年份:2011
-
负责人:LUCIO COMAI
-
依托单位:
Identification of Therapeutic Small Molecules for Myotonic Dystrophy Type 1
-
批准号:8337720
-
项目类别:
-
资助金额:$20.5万
-
财政年份:2011
-
负责人:LUCIO COMAI
-
依托单位:
Role of the Werner syndrome protein complex in the metabolism of chromosome ends
-
批准号:8240043
-
项目类别:
-
资助金额:$36.99万
-
财政年份:2010
-
负责人:LUCIO COMAI
-
依托单位:
Role of the Werner syndrome protein complex in the metabolism of chromosome ends
-
批准号:8441584
-
项目类别:
-
资助金额:$34.7万
-
财政年份:2010
-
负责人:LUCIO COMAI
-
依托单位:
Role of the Werner syndrome protein complex in the metabolism of chromosome ends
-
批准号:7888108
-
项目类别:
-
资助金额:$38.01万
-
财政年份:2010
-
负责人:LUCIO COMAI
-
依托单位:
Role of the Werner syndrome protein complex in the metabolism of chromosome ends
-
批准号:8045351
-
项目类别:
-
资助金额:$37.28万
-
财政年份:2010
-
负责人:LUCIO COMAI
-
依托单位:
Biochemical analyses of muscleblind complexes in myotonic dystrophy
-
批准号:7735572
-
项目类别:
-
资助金额:$49.36万
-
财政年份:2007
-
负责人:LUCIO COMAI
-
依托单位:
Biochemical analyses of muscleblind complexes in myotonic dystrophy
-
批准号:7352997
-
项目类别:
-
资助金额:$47.97万
-
财政年份:2007
-
负责人:LUCIO COMAI
-
依托单位:
Biochemical analyses of muscleblind complexes in myotonic dystrophy
-
批准号:7564050
-
项目类别:
-
资助金额:$48.9万
-
财政年份:2007
-
负责人:LUCIO COMAI
-
依托单位:
Biochemical analyses of muscleblind complexes in myotonic dystrophy
-
批准号:7989418
-
项目类别:
-
资助金额:$49.82万
-
财政年份:2007
-
负责人:LUCIO COMAI
-
依托单位:
Biochemical analyses of muscleblind complexes in myotonic dystrophy
-
批准号:8197219
-
项目类别:
-
资助金额:$49.82万
-
财政年份:2007
-
负责人:LUCIO COMAI
-
依托单位:
Biochemical analyses of muscleblind complexes in myotonic dystrophy
-
批准号:7869533
-
项目类别:
-
资助金额:$17.62万
-
财政年份:2007
-
负责人:LUCIO COMAI
-
依托单位:
The Werner syndrome protein in CPT-induced DNA damage
-
批准号:7243372
-
项目类别:
-
资助金额:$30.29万
-
财政年份:2004
-
负责人:LUCIO COMAI
-
依托单位:
The Werner syndrome protein in CPT-induced DNA damage
-
批准号:7069615
-
项目类别:
-
资助金额:$31.19万
-
财政年份:2004
-
负责人:LUCIO COMAI
-
依托单位:
The Werner syndrome protein in CPT-induced DNA damage
-
批准号:6897435
-
项目类别:
-
资助金额:$31.85万
-
财政年份:2004
-
负责人:LUCIO COMAI
-
依托单位:
The Werner syndrome protein in CPT-induced DNA damage
-
批准号:6768943
-
项目类别:
-
资助金额:$31.84万
-
财政年份:2004
-
负责人:LUCIO COMAI
-
依托单位:
VIRAL REGULATION OF RIBOSOMAL RNA TRANSCRIPTION
-
批准号:6490095
-
项目类别:
-
资助金额:$16.68万
-
财政年份:1998
-
负责人:LUCIO COMAI
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: